Lilly To Levy A Fat Tax For Its Weight Loss Drug in Canada If you're prescribed tirzepatide for obesity in Canada, come January, you'll be paying double what you would pay if you were prescribed it for type 2 diabetes Dusting off the blog because I just received a notice from drug giant Lilly that basically says theyre going to add a fat tax to tirzepatide (aka Mounjaro and Zepbound) such that if its prescribed to you for obesity, youre going to pay more than twice as much as if it were prescribed to you for type 2 diabetes
Liu J, Conde K, Zhang P, Lilascharoen V, Xu ZH, Lim BK, et al
we settle on a quiet bar near the lobby called Jim Bobs
If semaglutide fatigue is limiting your activity, even gentle movement is better than none
Probiotic treatment improves post-traumatic stress disorder outcomes in mice
But you can already see how the FDA cleared the way for BPC-157 will read on a vendor page, and how little of the nuance will survive the trip